3 Stocks That Have Doubled and Still Have Room to Grow
The S&P 500 is hovering near an all-time high and has had a great year in 2017, so it's not a surprise that many stocks have delivered exceptional performance recently. However, just because a stock has risen dramatically doesn't necessarily mean it's expensive -- even if the stock has doubled in price or more. As examples, here's why our Foolish investors believe Bank of America (NYSE: BAC), SolarEdge Technologies (NASDAQ: SEDG), and Vertex Pharmaceuticals (NASDAQ: VRTX) could all still be worth a look.
Matt Frankel (Bank of America): Bank of America is up 57% in 2017 alone and has gained nearly 140% since bottoming out in early 2016.
This gain has been well deserved. Not only is Bank of America's profitability getting closer and closer to where it needs to be, but the bank is also consistently profitable for the first time in years. Management has focused on investing in technology, improving efficiency, and pursuing smart risk management, and all of its efforts seem to be paying off.
Source: Fool.com
Vertex Pharmaceuticals Inc. Stock
With 58 Buy predictions and 2 Sell predictions Vertex Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 459 € shows a slightly positive potential of 4.73% compared to the current price of 438.25 € for Vertex Pharmaceuticals Inc..
